A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples